P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY

Objectives: To study whether inhibition of the renin-angiotensin-aldosterone system has effects on vascular function beyond blood pressure (BP) reduction alone. Methods: Mild-to-moderate hypertensive patients (age 54±12 years, 34% women) were randomized double-blind to ramipril (10 mg od, n=33) or...

Full description

Bibliographic Details
Main Authors: Andreas Jekell*, Majid Kalani, Thomas Kahan
Format: Article
Language:English
Published: BMC 2015-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930583/view
_version_ 1811300709854871552
author Andreas Jekell*
Majid Kalani
Thomas Kahan
author_facet Andreas Jekell*
Majid Kalani
Thomas Kahan
author_sort Andreas Jekell*
collection DOAJ
description Objectives: To study whether inhibition of the renin-angiotensin-aldosterone system has effects on vascular function beyond blood pressure (BP) reduction alone. Methods: Mild-to-moderate hypertensive patients (age 54±12 years, 34% women) were randomized double-blind to ramipril (10 mg od, n=33) or doxazosin (8 mg od, n=28) for 12 weeks. Central BP, pulse wave velocity (PWV), and augmentation index (AIx) were assessed by applanation tonometry (SphygmoCor, AtCor Medical). Endothelial function was studied by forearm post-ischemic flow mediated vasodilatation (FMD) and pulse wave analysis with beta 2-adrenoceptor-agonist stimulation, and by skin microcirculation iontophoresis (acetylcholine and sodium nitroprusside). Results: Baseline central and brachial BP were 140/89 and 148/89 mmHg, carotid and brachial pulse pressures 51 and 60 mmHg, carotid-femoral and carotid-radial PWV 8.8 and 8.9 m/s, and AIx 30.1%. Treatment induced reductions (means±SEM) in central and brachial BP (−7.9±1.1/−6.6±1.1 and −6.0±1.0/−6.8±1.1%; all P<0.001) with greater reductions in central BP (all P<0.05), carotid/brachial pulse pressure ratio (−4.7±1.7%; P<0.01), carotid-radial PWV (−2.9±2.0%; P<0.05), and AIx (−15.9±4.5%; P<0.01), but did not affect carotid-femoral PWV or carotid-femoral/carotid-radial PWV ratios. Ramipril induced greater changes than doxazosin in central and brachial systolic BP (−9.8±1.4 vs −5.4±1.6 and −7.9±1.3 vs −3.8±1.4%; all P<0.05) but central/brachial BP ratio reductions were similar. All endothelial function indices suggested normal endothelial function (eg FMD 5.5±4.1%, reflection index 0.79±0.06) with no treatment effects. Conclusions: Angiotensin converting enzyme-inhibition and alpha 1-adrenoceptor-blockade similarly reduce central BP more than brachial BP and improve indices of aortic stiffness. Evidence of endothelial dysfunction might require more advanced stages of hypertensive disease.
first_indexed 2024-04-13T06:56:20Z
format Article
id doaj.art-d1250eb7deed43bab5dfa083f12db1a2
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-04-13T06:56:20Z
publishDate 2015-11-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-d1250eb7deed43bab5dfa083f12db1a22022-12-22T02:57:15ZengBMCArtery Research1876-44012015-11-011210.1016/j.artres.2015.10.241P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDYAndreas Jekell*Majid KalaniThomas KahanObjectives: To study whether inhibition of the renin-angiotensin-aldosterone system has effects on vascular function beyond blood pressure (BP) reduction alone. Methods: Mild-to-moderate hypertensive patients (age 54±12 years, 34% women) were randomized double-blind to ramipril (10 mg od, n=33) or doxazosin (8 mg od, n=28) for 12 weeks. Central BP, pulse wave velocity (PWV), and augmentation index (AIx) were assessed by applanation tonometry (SphygmoCor, AtCor Medical). Endothelial function was studied by forearm post-ischemic flow mediated vasodilatation (FMD) and pulse wave analysis with beta 2-adrenoceptor-agonist stimulation, and by skin microcirculation iontophoresis (acetylcholine and sodium nitroprusside). Results: Baseline central and brachial BP were 140/89 and 148/89 mmHg, carotid and brachial pulse pressures 51 and 60 mmHg, carotid-femoral and carotid-radial PWV 8.8 and 8.9 m/s, and AIx 30.1%. Treatment induced reductions (means±SEM) in central and brachial BP (−7.9±1.1/−6.6±1.1 and −6.0±1.0/−6.8±1.1%; all P<0.001) with greater reductions in central BP (all P<0.05), carotid/brachial pulse pressure ratio (−4.7±1.7%; P<0.01), carotid-radial PWV (−2.9±2.0%; P<0.05), and AIx (−15.9±4.5%; P<0.01), but did not affect carotid-femoral PWV or carotid-femoral/carotid-radial PWV ratios. Ramipril induced greater changes than doxazosin in central and brachial systolic BP (−9.8±1.4 vs −5.4±1.6 and −7.9±1.3 vs −3.8±1.4%; all P<0.05) but central/brachial BP ratio reductions were similar. All endothelial function indices suggested normal endothelial function (eg FMD 5.5±4.1%, reflection index 0.79±0.06) with no treatment effects. Conclusions: Angiotensin converting enzyme-inhibition and alpha 1-adrenoceptor-blockade similarly reduce central BP more than brachial BP and improve indices of aortic stiffness. Evidence of endothelial dysfunction might require more advanced stages of hypertensive disease.https://www.atlantis-press.com/article/125930583/view
spellingShingle Andreas Jekell*
Majid Kalani
Thomas Kahan
P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
Artery Research
title P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
title_full P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
title_fullStr P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
title_full_unstemmed P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
title_short P3.17 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY RAMIPRIL ON CENTRAL AND BRACHIAL BLOOD PRESSURE AND VASCULAR REACTIVITY IN MILD-TO-MODERATE HYPERTENSION: THE DOXAZOSIN RAMIPRIL STUDY
title_sort p3 17 the effects of alpha 1 adrenoceptor blockade by doxazosin and angiotensin converting enzyme inhibition by ramipril on central and brachial blood pressure and vascular reactivity in mild to moderate hypertension the doxazosin ramipril study
url https://www.atlantis-press.com/article/125930583/view
work_keys_str_mv AT andreasjekell p317theeffectsofalpha1adrenoceptorblockadebydoxazosinandangiotensinconvertingenzymeinhibitionbyramipriloncentralandbrachialbloodpressureandvascularreactivityinmildtomoderatehypertensionthedoxazosinramiprilstudy
AT majidkalani p317theeffectsofalpha1adrenoceptorblockadebydoxazosinandangiotensinconvertingenzymeinhibitionbyramipriloncentralandbrachialbloodpressureandvascularreactivityinmildtomoderatehypertensionthedoxazosinramiprilstudy
AT thomaskahan p317theeffectsofalpha1adrenoceptorblockadebydoxazosinandangiotensinconvertingenzymeinhibitionbyramipriloncentralandbrachialbloodpressureandvascularreactivityinmildtomoderatehypertensionthedoxazosinramiprilstudy